[PDF] Top 20 Postmenopausal hormone therapy and asthma onset in the E3N cohort.
Has 10000 "Postmenopausal hormone therapy and asthma onset in the E3N cohort." found on our website. Below are the top 20 most common "Postmenopausal hormone therapy and asthma onset in the E3N cohort.".
Postmenopausal hormone therapy and asthma onset in the E3N cohort.
... of asthma onset in postmenopausal women with increasing weight points to an endocrine mechanism such as increased endogenous estrogen ...Menopausal hormone therapy (MHT) might ... Voir le document complet
27
Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort.
... is the range of MHTs evaluated and the fact that exposure was regularly updated during ...never-users, and users of a given MHT, which can occur in prospective studies with a single ... Voir le document complet
16
Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
... 21. Douketis JD, Julian JA, Kearon C, Anderson DR, Crowther MA, Bates SM, Barone M, Piovella F, Turpie AG, Middeldorp S, van Nguyen P, Prandoni P, Wells PS, Kovacs MJ, MacGillavry MR, Costantini L, Ginsberg JS. Does ... Voir le document complet
26
Body mass index, change in body silhouette, and risk of asthma in the E3N cohort study.
... that the timing of weight gain needs to be ...that in our population, silhouette at menarche was inversely related to age at menarche (p < ...supports the validity of the women’s reports of ... Voir le document complet
12
Estimated numbers of postmenopausal women treated by hormone therapy in France.
... by the four age groups. However the authors did not standardize on French national census and the study concerned women aged over 55 ...underestimate the prevalence ...a cohort ... Voir le document complet
12
Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.
... to the use of natural progesterone, in sharp contrast with those referring to the use of progestins, are ...two cohort studies carried out in France, where oral micronized progesterone ... Voir le document complet
19
Hormone levels and cognitive function in postmenopausal midlife women.
... function. Postmenopausal midlife women in the population- based Melbourne Women’s Midlife Health Project cohort were administered a comprehensive battery of neuropsychological tests on two ... Voir le document complet
32
Breast cancer and hormonal therapy in postmenopausal women
... from the Women’s Health Initiative (WHI) that the risk of breast cancer associated with the use of combined menopausal hormone therapy (HT) markedly decreased after treatment ...used ... Voir le document complet
3
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.
... of hormone replacement therapies (HRTs) are available for the treatment of menopausal ...risk. The goal of this study was to assess and compare the association between different HRTs ... Voir le document complet
11
Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women.
... decrease in postmenopausal breast cancer risk associated with past OC use and the decrease in risk with increasing time since first use support the hypothesis that some women ... Voir le document complet
11
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
... center and age at recruitment with further adjustments for age at menarche (less than 11 years, 11 to 14 years and greater than 14 years, missing), age at first child birth (less than 20 years, 20 to 30 ... Voir le document complet
15
Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohorts Running title: Evolution of HT use in France
... status and use (current and past) of hormonal treatments, as detailed ...initiation and periods compared Women were considered naturally postmenopausal if they reported amenorrhea for more ... Voir le document complet
10
Progestogens and venous thromboembolism among postmenopausal women using hormone therapy.
... difference in VTE risk did not reach the signification (Hazard ...to the other progestogens, the ESTHER (EStrogen and THromboEmbolism Risk) Study, a French case/control study of VTE ... Voir le document complet
22
Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
... that the constructed menopause variables were as accurate as possible, date of menopause, type of menopause, date of last menstruation, date of start of menopausal symptoms and date of hysterectomy were ... Voir le document complet
13
Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort
... variable in our statistical models, starting from the first questionnaire answered after menopause and updated at the date of answer of each follow-up questionnaire: the exposure ... Voir le document complet
24
Recent Recreational Physical Activity and Breast Cancer Risk in Postmenopausal Women in the E3N Cohort
... of the studies examining BMI, in that they did not find it to be an intermediate factor or a potential effect modifier in the relation between physical activity and breast cancer ... Voir le document complet
11
[Fat consumption and breast cancer: preliminary results from the E3N-Epic cohort]
... increase the risk of breast ...on the type of study; indeed, most of the prospective studies do not support this ...association. In this paper, we investigated the relationship between ... Voir le document complet
7
A validation study on status and age of natural menopause reported in the E3N cohort.
... uncertain and who replied that they had an unsettled menopause were classified as ...from the analysis would enhance the kappa coefficients for the menopausal status to ...(P<0.0001). ... Voir le document complet
5
Effect of hormone replacement therapy on retinal and optic nerve head blood flow and topography in postmenopausal women, and retinal tissue perfusion in ovariectomized rats
... author and co-authors if applicable retain copyright ownership and moral rights in this ...Neither the whole thesis or dissertation, nor substantial extracts from it, may be printed or ... Voir le document complet
324
Title: Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
... size, hormone therapy and risk of breast cancer in Asian-American ...Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting ... Voir le document complet
27
Sujets connexes